STRATA Historical Cash Flow
| SSKN Stock | USD 2.14 0.07 3.17% |
Analysis of STRATA Skin cash flow over time is an excellent tool to project STRATA Skin Sciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 2.2 M or Capital Expenditures of 2.1 M as it is a great indicator of STRATA Skin ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining STRATA Skin Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether STRATA Skin Sciences is a good buy for the upcoming year.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. About STRATA Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in STRATA balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which STRATA's non-liquid assets can be easily converted into cash.
STRATA Skin Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by STRATA Skin Sciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of STRATA Skin operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from STRATA Skin's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into STRATA Skin Sciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. At this time, STRATA Skin's Change Receivables is very stable compared to the past year. As of the 23rd of July 2025, Change To Operating Activities is likely to grow to about 1.5 M, while Sale Purchase Of Stock is likely to drop about 19.7 K.
STRATA Skin cash flow statement Correlations
Click cells to compare fundamentals
STRATA Skin Account Relationship Matchups
High Positive Relationship
High Negative Relationship
STRATA Skin cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 2.5M | (5.5M) | (5.8M) | 1.3M | 477K | 312.3K | |
| Free Cash Flow | (63K) | (2.1M) | (4.7M) | (5.5M) | (1.4M) | (1.5M) | |
| Change In Working Capital | 596K | 324K | (3.1M) | (69K) | 688K | 452.5K | |
| Total Cashflows From Investing Activities | (2.2M) | (7.1M) | (4.2M) | (5.0M) | (1.6M) | (1.7M) | |
| Other Cashflows From Financing Activities | 18K | (133K) | (500K) | (139K) | (18K) | (17.1K) | |
| Depreciation | 3.9M | 4.1M | 5.7M | 5.9M | 5.3M | 3.0M | |
| Other Non Cash Items | 114K | (1.9M) | 316K | 3.3M | 4.0M | 2.2M | |
| Capital Expenditures | 2.2M | 3.7M | 3.6M | 5.0M | 1.6M | 2.1M | |
| Total Cash From Operating Activities | 2.1M | 1.5M | (1.1M) | (519K) | 188K | 197.4K | |
| Net Income | (4.4M) | (2.7M) | (5.5M) | (10.8M) | (10.1M) | (10.6M) | |
| Total Cash From Financing Activities | 2.5M | 92K | (500K) | 6.9M | 1.9M | 1.8M | |
| End Period Cash Flow | 18.1M | 12.6M | 6.8M | 8.1M | 8.6M | 10.3M | |
| Change To Inventory | (417K) | (45K) | (1.5M) | 689K | 162K | 170.1K | |
| Begin Period Cash Flow | 15.6M | 18.1M | 12.6M | 6.8M | 8.1M | 10.4M | |
| Change To Account Receivables | 1.4M | (490K) | (1.1M) | 141K | (631K) | (599.5K) | |
| Other Cashflows From Investing Activities | (2.7M) | (2.1M) | (3.5M) | (631K) | (725.7K) | (761.9K) | |
| Change To Liabilities | 433K | 540K | 314K | (386K) | (347.4K) | (330.0K) | |
| Stock Based Compensation | 1.6M | 1.6M | 1.5M | 1.3M | 427K | 405.7K | |
| Change To Netincome | 978K | 1.1M | 2.0M | (233K) | (209.7K) | (199.2K) | |
| Net Borrowings | (3.4M) | (296K) | 2.5M | 225K | 202.5K | 192.4K | |
| Change To Operating Activities | 563K | 287K | (653K) | 1.2M | 1.4M | 1.5M | |
| Investments | (2.2M) | (7.1M) | (4.2M) | (4.7M) | (1.6M) | (1.7M) |
Pair Trading with STRATA Skin
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if STRATA Skin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STRATA Skin will appreciate offsetting losses from the drop in the long position's value.Moving against STRATA Stock
| 0.79 | VEEV | Veeva Systems Class | PairCorr |
| 0.72 | VNRX | Volitionrx | PairCorr |
| 0.7 | DH | Definitive Healthcare | PairCorr |
| 0.59 | LH | Laboratory Earnings Call Tomorrow | PairCorr |
| 0.56 | GH | Guardant Health | PairCorr |
The ability to find closely correlated positions to STRATA Skin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace STRATA Skin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back STRATA Skin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling STRATA Skin Sciences to buy it.
The correlation of STRATA Skin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as STRATA Skin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if STRATA Skin Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for STRATA Skin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.27) | Revenue Per Share | Quarterly Revenue Growth 0.009 | Return On Assets | Return On Equity |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.